myfortic 360 mg enterotabletter
novartis healthcare a/s - mycophenolatnatrium - enterotabletter - 360 mg
myfortic 180 mg enterotabletter
orifarm a/s - mycophenolatnatrium - enterotabletter - 180 mg
myfortic 360 mg enterotabletter
orifarm a/s - mycophenolatnatrium - enterotabletter - 360 mg
bindren
mitsubishi pharma europe ltd - colestilan - hyperfosfatæmi - lægemidler til behandling af hyperkaliæmi og hyperphosphatæmi - behandling af hyperphosphatæmi hos voksne patienter med kronisk nyresygdom, fase 5, der modtager hæmodialyse eller peritonealdialyse.
veltassa
vifor fresenius medical care renal pharma france - patiromer sorbitex calcium - hyperkaliæmi - lægemidler til behandling af hyperkaliæmi og hyperphosphatemia - veltassa er indiceret til behandling af hyperkaliæmi hos voksne.
lupkynis
otsuka pharmaceutical netherlands b.v. - voclosporin - lupus nephritis - immunosuppressiva - lupkynis is indicated in combination with mycophenolate mofetil for the treatment of adult patients with active class iii, iv or v (including mixed class iii/v and iv/v) lupus nephritis (ln).
sevelamercarbonat "stada" 800 mg filmovertrukne tabletter
stada arzneimittel ag - sevelamer carbonate - filmovertrukne tabletter - 800 mg
sevelamercarbonat "stada arzneimittel ag" 800 mg filmovertrukne tabletter
stada arzneimittel ag - sevelamer carbonate - filmovertrukne tabletter - 800 mg